Letters Regarding DMAA

May 8, 2013

Excerpt: FDA stated that the information USPlabs submitted was ‘insufficient to defend the use of DMAA as an ingredient in dietary supplements’ and advised consumers not to buy or use any products containing the stimulant. FDA subsequently asserted that it could ban an unsafe ingredient in a dietary supplement, though the agency is required to ‘undertake a series of lengthy scientific and legal steps’ in doing so. In addition to banning certain ingredients, the agency said that ‘FDA can also take a seizure action to remove the products from the market or obtain an injunction against a company to prevent it from manufacturing and distributing illegal products.’

To read the letter to FDA, click here.

To read the letter to GNC, click here.

To read the letter to USPlabs, click here.

To read the letter to Vitamin Shoppe, click here

To read a related press release, click here.

Letter Type: